Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Other Non Operating Income (2022 - 2025)

60 Degrees Pharmaceuticals (SXTP) has disclosed Other Non Operating Income for 4 consecutive years, with $31550.0 as the latest value for Q3 2025.

  • On a quarterly basis, Other Non Operating Income rose 89.8% to $31550.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $109044.0, a 98.37% decrease, with the full-year FY2024 number at $101464.0, down 98.11% from a year prior.
  • Other Non Operating Income was $31550.0 for Q3 2025 at 60 Degrees Pharmaceuticals, up from $13066.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $6.6 million in Q4 2023 to a low of -$839887.0 in Q1 2023.
  • A 4-year average of $464071.2 and a median of $18153.5 in 2024 define the central range for Other Non Operating Income.
  • Peak YoY movement for Other Non Operating Income: skyrocketed 49981.77% in 2023, then plummeted 99.48% in 2024.
  • 60 Degrees Pharmaceuticals' Other Non Operating Income stood at $13184.0 in 2022, then surged by 49981.77% to $6.6 million in 2023, then tumbled by 99.48% to $34106.0 in 2024, then decreased by 7.49% to $31550.0 in 2025.
  • Per Business Quant, the three most recent readings for SXTP's Other Non Operating Income are $31550.0 (Q3 2025), $13066.0 (Q2 2025), and $30322.0 (Q1 2025).